Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$4.82 - $8.26 $17,323 - $29,686
3,594 Added 9.2%
42,653 $219,000
Q4 2023

Jan 25, 2024

BUY
$3.58 - $6.25 $139,831 - $244,118
39,059 New
39,059 $223,000
Q4 2022

Jan 23, 2023

SELL
$5.57 - $11.01 $83 - $165
-15 Reduced 2.22%
661 $0
Q3 2022

Oct 26, 2022

BUY
$5.34 - $12.79 $3,609 - $8,646
676 New
676 $7,000
Q2 2022

Jul 25, 2022

SELL
$5.1 - $9.74 $41,019 - $78,338
-8,043 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$8.42 - $15.32 $118,890 - $216,318
-14,120 Reduced 63.71%
8,043 $73,000
Q4 2021

Jan 28, 2022

BUY
$14.59 - $23.26 $323,358 - $515,511
22,163 New
22,163 $334,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $91.9M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.